Shackelford, Rodney E <br/><br/>
Pharmacologic manipulation of the ataxia-telangiectasia mutated gene product as an intervention in age-related disease.  [electronic resource] 

 -  Medical hypotheses  2005 
 - 363-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0306-9877 
<br/><br/><label>Standard No.: </label>10.1016/j.mehy.2005.02.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aging<br/>Animals<br/>Antioxidants--metabolism<br/>Ataxia Telangiectasia Mutated Proteins<br/>Catechin--analogs & derivatives<br/>Cell Cycle Proteins--genetics<br/>DNA-Binding Proteins--genetics<br/>Enzyme Inhibitors--pharmacology<br/>Genistein--pharmacology<br/>Humans<br/>Insulin-Like Growth Factor I--metabolism<br/>Mice<br/>Models, Biological<br/>Models, Theoretical<br/>Mutation<br/>Oxidants--metabolism<br/>Protein Serine-Threonine Kinases--genetics<br/>Quercetin--pharmacology<br/>Signal Transduction<br/>Tumor Suppressor Protein p53--metabolism<br/>Tumor Suppressor Proteins--genetics